Cronos Group (CRON) Competitors C$3.57 +0.03 (+0.85%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CRON vs. BHC, AUP, CARA, TLRY, SLS, TEV, ABT, NOT, PYR, and NVOShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Tilray Brands (TLRY), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), and Novo Resources Corp. (NVO.V) (NVO). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Bausch Health Companies Aurinia Pharmaceuticals Cara Operations Tilray Brands Solaris Resources Tervita Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings. Is BHC or CRON more profitable? Bausch Health Companies has a net margin of -1.88% compared to Cronos Group's net margin of -42.65%. Bausch Health Companies' return on equity of 15.87% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Companies-1.88% 15.87% 4.16% Cronos Group -42.65%-4.40%-3.73% Which has better earnings & valuation, BHC or CRON? Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Cronos Group is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health CompaniesC$6.69B0.38-C$125.65M-C$0.68-14.38Cronos GroupC$76.86M12.27-C$32.78M-C$0.18-19.86 Which has more volatility & risk, BHC or CRON? Bausch Health Companies has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Do institutionals and insiders hold more shares of BHC or CRON? 79.0% of Bausch Health Companies shares are held by institutional investors. Comparatively, 16.0% of Cronos Group shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to BHC or CRON? In the previous week, Bausch Health Companies had 12 more articles in the media than Cronos Group. MarketBeat recorded 15 mentions for Bausch Health Companies and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.13 beat Bausch Health Companies' score of 0.05 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Companies 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cronos Group 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer BHC or CRON? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryBausch Health Companies beats Cronos Group on 8 of the 14 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$942.71MC$2.19BC$5.78BC$6.40BDividend YieldN/A2.92%3.95%6.72%P/E Ratio-19.864.3131.2666.88Price / Sales12.27645.66464.641,650.19Price / Cash1.6710.3737.7383.29Price / Book1.2111.4310.045.33Net Income-C$32.78MC$20.70BC$3.27BC$301.20M7 Day Performance0.56%2.00%3.17%4.06%1 Month Performance26.15%4.44%4.34%4.78%1 Year Performance23.10%5.06%44.12%32.70% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos GroupN/AC$3.57+0.8%N/A+20.0%C$942.71MC$76.86M-19.86450News CoverageBHCBausch Health CompaniesN/AC$10.48-2.9%N/A+25.3%C$2.73BC$6.69B-15.3419,900Analyst RevisionAUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading VolumeCARACara OperationsN/AN/AN/AN/AC$1.62BN/A0.0080TLRYTilray BrandsN/AC$1.43-1.4%N/A-19.5%C$921.45MC$610.34M-3.462,650Gap UpSLSSolaris Resources1.3761 of 5 starsC$7.40-0.7%C$12.50+68.9%+136.7%C$848.89MN/A-12.8910TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400News Coverage Related Companies and Tools Related Companies Bausch Health Companies Alternatives Aurinia Pharmaceuticals Alternatives Cara Operations Alternatives Tilray Brands Alternatives Solaris Resources Alternatives Tervita Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access